Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

‘Priority pathogens’ list underscores urgent need for new antibiotics
Antibiotics
The list is split into three categories according to the urgency of the need for new antibiotics
WHO list designed to guide and promote research

A list of 12 bacteria families that pose the greatest threat to human health has been published by the World Health Organisation (WHO).

Designed to guide and promote research of new antibiotics, the “priority pathogens” list forms part of WHO’s effort to address the global spread of antimcrobial resistance.

In particular, the list highlights the threat of gram-negative bacteria that are resistant to many antibiotics. These bacteria have the ability to find new ways to resist treatment and can transfer genetic material to other bacteria, allowing them to also become drug-resistant.

"This list is a new tool to ensure R&D responds to urgent public health needs," says Dr Marie-Paule Kieny, WHO's assistant director-general for health systems and innovation. "Antibiotic resistance is growing, and we are fast running out of treatment options. If we leave it to market forces alone, the new antibiotics we most urgently need are not going to be developed in time.”

The list is split into three categories according to the urgency of the need for new antibiotics: critical, high and medium priority.

The critical group contains multi-drug resistant bacteria that constitute a particular threat in nursing homes and hospitals. These include Acinetobacter, Pseudomonas and various Enterobacteriaceae.

The high and medium-priority lists contain drug-resistant bacteria that cause more common diseases, such as Salmonella and gonorrhoea. Tuberculosis – whose resistance has been growing in recent years – was not included because other programmes are already targeting this.  

WHO hopes that the list will spur governments to introduce policies that encourage basic science and advanced R&D. They also hope the list will inform not-for-profit projects such as the WHO/Drugs for Neglected Diseases initiative (DNDi), which is participating in development of new antibiotics.

"New antibiotics targeting this priority list of pathogens will help to reduce deaths due to resistant infections around the world," says Prof Evelina Tacconelli, head of the division of infectious diseases at the University of Tübingen and a major contributor to the development of the list. "Waiting any longer will cause further public health problems and dramatically impact on patient care."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.